Copyright
©The Author(s) 2024.
World J Gastroenterol. Apr 28, 2024; 30(16): 2184-2190
Published online Apr 28, 2024. doi: 10.3748/wjg.v30.i16.2184
Published online Apr 28, 2024. doi: 10.3748/wjg.v30.i16.2184
What is already known about miRNAs in IBD? | What can we expect from miRNAs in IBD? | Ref. |
Regulate cellular processes and homeostasis | Discover new functions in the pathophysiology of IBD | [8-11] |
Differentially expressed between patients with IBD and healthy controls | Can be used as diagnostic markers for IBD | [5,6,16-19] |
Differentially expressed between UC and CD | Can be used to differentiate UC from CD | [6] |
Differentially expressed with respect to disease activity | Can be used as biomarkers of inflammatory activity | [16,17,19,32] |
Regulated in response to drug exposure | Can be used as markers of drug responses | [20] |
Regulate the expression of inflammatory cytokines | Potential therapeutic targets in IBD | [21,22,23] |
Act on the intestinal barrier | Potential therapeutic targets in IBD | [25,26] |
Modulate the intestinal microbiota | Potential therapeutic targets in IBD | [27-29] |
- Citation: Oliveira ECS, Quaglio AEV, Grillo TG, Di Stasi LC, Sassaki LY. MicroRNAs in inflammatory bowel disease: What do we know and what can we expect? World J Gastroenterol 2024; 30(16): 2184-2190
- URL: https://www.wjgnet.com/1007-9327/full/v30/i16/2184.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i16.2184